Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis

SIMPLE SUMMARY: The role of serum Cyfra 21.1 as a biomarker in thyroid cancer has yet to be validated. This study investigated the diagnostic or prognostic role of serum Cyfra 21.1 in thyroid cancer. In the present analysis, we found that serum Cyfra 21.1 was increased in thyroid cancer with distant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Chaiho, Lee, Jeongmin, Yoon, Hyukjin, Ha, Jeonghoon, Kim, Min-Hee, Bae, Ja-Seong, Jung, Chan-Kwon, Kim, Jeong-Soo, Kang, Moo-Il, Lim, Dong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919275/
https://www.ncbi.nlm.nih.gov/pubmed/33671989
http://dx.doi.org/10.3390/cancers13040811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919275/
https://www.ncbi.nlm.nih.gov/pubmed/33671989
http://dx.doi.org/10.3390/cancers13040811

Ejemplares similares